Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $85.04 | 6 | 87.2% |
| Education | $12.45 | 1 | 12.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $22.86 | 1 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $16.00 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $13.01 | 1 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $12.45 | 1 | $0 (2019) |
| Astellas Pharma US Inc | $12.07 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $10.77 | 1 | $0 (2018) |
| Amgen Inc. | $10.33 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $48.32 | 3 | Novartis Pharmaceuticals Corporation ($22.86) |
| 2018 | $10.77 | 1 | Janssen Pharmaceuticals, Inc ($10.77) |
| 2017 | $38.40 | 3 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($16.00) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.01 | General |
| Category: Cardiovascular | ||||||
| 04/26/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/29/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Education | In-kind items and services | $12.45 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 10/25/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/19/2017 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: Cardiology | ||||||
| 08/23/2017 | Astellas Pharma US Inc | Lexiscan (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: Cardiology | ||||||
| 05/11/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 537 | 552 | $86,361 | $21,832 |
| 2022 | 15 | 1,142 | 1,267 | $165,181 | $56,067 |
| 2021 | 18 | 1,740 | 1,969 | $271,947 | $109,457 |
| 2020 | 16 | 1,583 | 1,737 | $283,958 | $97,944 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 161 | 162 | $32,400 | $7,853 | 24.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 40 | $7,280 | $3,565 | 49.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 51 | 51 | $11,934 | $2,829 | 23.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 34 | 34 | $6,018 | $2,233 | 37.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 42 | 42 | $9,828 | $1,938 | 19.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 30 | 30 | $6,000 | $1,246 | 20.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 56 | 56 | $4,928 | $889.92 | 18.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 56 | 56 | $3,416 | $595.67 | 17.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 47 | 47 | $2,867 | $406.78 | 14.2% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 12 | 12 | $1,008 | $158.07 | 15.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 22 | 22 | $682.00 | $116.77 | 17.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 331 | 414 | $46,368 | $22,477 | 48.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 174 | 175 | $35,000 | $8,584 | 24.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 33 | 51 | $9,282 | $4,009 | 43.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 44 | 48 | $8,496 | $3,651 | 43.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 44 | 44 | $7,348 | $3,348 | 45.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 56 | 56 | $13,104 | $3,247 | 24.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 40 | $5,080 | $2,026 | 39.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 25 | 25 | $5,850 | $1,318 | 22.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $2,868 | $1,285 | 44.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 15 | $2,475 | $1,215 | 49.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 60 | 61 | $5,368 | $1,037 | 19.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 103 | 104 | $8,320 | $915.72 | 11.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 11 | 11 | $4,072 | $879.48 | 21.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 61 | 62 | $3,782 | $702.52 | 18.6% |
About Dr. John Longabaugh, MD
Dr. John Longabaugh, MD is a Cardiovascular Disease healthcare provider based in Toledo, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1225032592.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Longabaugh, MD has received a total of $97.49 in payments from pharmaceutical and medical device companies, with $48.32 received in 2019. These payments were reported across 7 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($85.04).
As a Medicare-enrolled provider, Longabaugh has provided services to 5,002 Medicare beneficiaries, totaling 5,525 services with total Medicare billing of $285,299. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Toledo, OH
- Active Since 06/02/2005
- Last Updated 11/03/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1225032592
Products in Payments
- ENTRESTO (Drug) $22.86
- LifeVest (Device) $16.00
- ELIQUIS (Drug) $13.01
- PRALUENT (Biological) $12.45
- Lexiscan (Drug) $12.07
- XARELTO (Drug) $10.77
- Corlanor (Drug) $10.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Toledo
Dr. William Colyer, M.d, M.D
Cardiovascular Disease — Payments: $170,681
Rajendra Kattar, Md, MD
Cardiovascular Disease — Payments: $159,921
Dr. Muhammad Talha Ayub, M.d, M.D
Cardiovascular Disease — Payments: $64,002
Abhishek Maan, M.d., Scm, M.D., SCM
Cardiovascular Disease — Payments: $36,935
P Ramanathan, Md, MD
Cardiovascular Disease — Payments: $33,301
Dr. Paul Chacko, M.d, M.D
Cardiovascular Disease — Payments: $27,239